Bio-Rad Laboratories (BIO) Revenue Growth (1y) (2010 - 2026)
Bio-Rad Laboratories (BIO) Revenue Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | 16.70% |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | 7.41% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 15.05% |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 6.08% |
| 10 | Bio-Rad Laboratories | 8.52 Bn | 6.95 Bn | 309.40 Mn | 1.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14% |
| Dec 31, 2025 | 3.85% |
| Sep 30, 2025 | 0.51% |
| Jun 30, 2025 | 2.05% |
| Mar 31, 2025 | -4.16% |
| Dec 31, 2024 | -2.01% |
| Sep 30, 2024 | 2.78% |
| Jun 30, 2024 | -6.25% |
| Mar 31, 2024 | -9.75% |
| Dec 31, 2023 | -6.72% |
| Sep 30, 2023 | -7.15% |
| Jun 30, 2023 | -1.45% |
| Mar 31, 2023 | -3.33% |
| Dec 31, 2022 | -0.34% |
| Sep 30, 2022 | -8.86% |
| Jun 30, 2022 | -3.46% |
| Mar 31, 2022 | -3.67% |
| Dec 31, 2021 | -7.22% |
| Sep 30, 2021 | 15.40% |
| Jun 30, 2021 | 33.34% |